Extended pharmacist role benefits patients

A trial where pharmacists are given greater responsibilities in managing patients who take certain drugs has yielded positive results for patients.

The trial, which only involved the management of patients on Warfarin, has been running in 15 community pharmacies across New Zealand for six months.

The results showed that  not only is it safe for pharmacists to manage treatment of Warfarin, but many patients with heart disease also find it more convenient than having to visit their doctor. 

During the trial, pharmacists conducted finger prick blood tests in the pharmacy, advised patients on how to manage their medication and demonstrated how they can modify their dose if required.

Results showed that anticoagulant control blood test results improved significantly for those who took part, reducing the risk of stroke.

Pharmacists reported that they welcomed the opportunity to make better use of their skills, while GPs and practice nurses reported that the pharmacy management model saved up to five hours per week of practice time.

The results of the trial were analysed by the University of Auckland, which recommended that the pharmacy model should be rolled out to all eligible patients across the country. The government estimates this would help to save millions of dollars each year.